Mackenzie Financial »

Allogene Therapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $894k 430k 2.08
2023-06-30 $264k 53k 4.96

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Toronto-Dominion Bank/The Common Stock (TD)
State Street Corp Etp (SPY)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Bank of Montreal Common Stock (BMO)
Alphabet Common Stock (GOOGL)
Canadian Pacific Kansas City L Common Stock (CP)
Microsoft Corp Common Stock (MSFT)
Agnico Eagle Mines Common Stock (AEM)
Canadian Imperial Bank of Comm Common Stock (CM)
Manulife Financial Corp Common Stock (MFC)
Enbridge Common Stock (ENB)
Canadian Natural Resources Common Stock (CNQ)
Amazon.com Common Stock (AMZN)

View all positions for Mackenzie Financial

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics